MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qad.0000000000002166

Медицинская библиотека · AIDS (London, England) · 2019

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.

Moyo Sikhulile, Gaseitsiwe Simani, Zahralban-Steele Melissa, Maruapula Dorcas, Nkhisang Tapiwa, Mokaleng Baitshepi, Mohammed Terence, Ditlhako Tsotlhe R, Bareng Ontlametse T, Mokgethi Thatayaone P, van Widenfelt Erik, Pretorius-Holme Molly, Mine Madisa O, Raizes Elliot, Yankinda Etienne Kadima, Wirth Kathleen E, Gaolathe Tendani, Makhema Joseph M, Lockman Shahin, Essex Max, Novitsky Vlad

СтатьяПоддержка исследования: вне правительства СШАПоддержка правительства СШАПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Scale-up of antiretroviral therapy (ART) and introduction of treat-all strategy necessitates population-level monitoring of acquired HIV drug resistance (ADR) and pretreatment drug resistance (PDR) mutations.

METHODS

Blood samples were collected from 4973 HIV-positive individuals residing in 30 communities across Botswana who participated in the Botswana Combination Prevention Project (BCPP) in 2013-2018. HIV sequences were obtained by long-range HIV genotyping. Major drug-resistance mutations (DRMs) and surveillance drug resistance mutations (SDRMs) associated with nucleoside reverse transcriptase inhibitors (NRTI) and nonnucleoside reverse transcriptase inhibitors (NNRTI) were analyzed according to the Stanford University HIV Drug Resistance Database. Viral sequences were screened for G-to-A hypermutations. A threshold of 2% was used for hypermutation adjustment. Viral suppression was considered at HIV-1 RNA load ≤400 copies/ml.

RESULTS

Among 4973 participants with HIV-1C sequences, ART data were available for 4927 (99%) including 3858 (78%) on ART. Among those on ART, 3435 had viral load data and 3297 (96%) were virologically suppressed. Among 1069 (22%) HIV-infected individuals not on ART, we found NRTI-associated and NNRTI-associated SDRMs were found in 1.5% (95% confidence interval [CI] 1.0-2.5%) and 2.9% (95% CI 2.0-4.2%), respectively. Of the 138 (4%) of individuals who had detectable HIV-1 RNA, we found NRTI-associated and NNRTI-associated drug resistance mutations in 16% (95% CI 10-25%) and 33% (95% CI 25-42%), respectively.

CONCLUSION

We found a low prevalence of NRTI-associated and NNRTI-associated PDR-resistance mutations among residents of rural and peri-urban communities across Botswana. However, individuals on ART with detectable virus had ADR NRTI and NNRTI mutations above 15%.

Для цитирования: Moyo Sikhulile, Gaseitsiwe Simani, Zahralban-Steele Melissa, Maruapula Dorcas, Nkhisang Tapiwa, Mokaleng Baitshepi, Mohammed Terence, Ditlhako Tsotlhe R, Bareng Ontlametse T, Mokgethi Thatayaone P, van Widenfelt Erik, Pretorius-Holme Molly, Mine Madisa O, Raizes Elliot, Yankinda Etienne Kadima, Wirth Kathleen E, Gaolathe Tendani, Makhema Joseph M, Lockman Shahin, Essex Max, Novitsky Vlad. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.. AIDS (London, England). 2019. DOI: 10.1097/qad.0000000000002166.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.